Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
Little is known of the changes in human immunodeficiency virus type 1 (HIV-1)-specific effector cytotoxic T lymphocytes (CTL) after potent antiretroviral therapy. Using HLA/peptide tetrameric complexes, we show that after starting treatment, there are early rapid fluctuations in the HIV-1-specific C...
Main Authors: | Ogg, G, Jin, X, Bonhoeffer, S, Moss, P, Nowak, M, Monard, S, Segal, J, Cao, Y, Rowland-Jones, S, Hurley, A, Markowitz, M, Ho, D, Mcmichael, A, Nixon, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1999
|
Similar Items
-
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
by: Ogg, G, et al.
Published: (1998) -
An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
by: Jin, X, et al.
Published: (2000) -
Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.
by: Goulder, P, et al.
Published: (1997) -
Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
by: Kalams, SA, et al.
Published: (1999) -
High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals.
by: Gotch, F, et al.
Published: (1990)